HCA Healthcare Inc (NYSE: HCA) has reported E.P.S. of $5.93 for its first fiscal quarter (ending March 31) versus $4.92 for the same period a year ago — an increase of 21%. Relative to the consensus estimate of $5.70, this was a premium of $0.23. For the latest four quarters through March 31, E.P.S. were $20.28 compared to $20.26 a year ago — an increase of 0%.
Recent Price Action
On 4/26/24, HCA Healthcare Inc (NYSE: HCA) stock declined by -2.4%, closing at $306.69. Moreover, exceptionally high trading volume at 215% of normal accompanied the decline. The stock has risen 3.3% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, HCA is expected to be an important Value Eraser.
HCA Healthcare is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment